SYK vs UHS
Stryker Corporation vs Universal Health Services — AI-powered side-by-side comparison
SYK
Stryker Corporation
59
Buy
VS
UHS
Universal Health Services
66
Buy
| Metric | SYK | UHS |
|---|
| AI Score |
59
|
66
|
| Price |
$330.05
|
$178.76
|
| P/E Ratio |
33.98×
|
7.13×
|
| ROE |
14.5%
|
20.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
65.2%
|
90.7%
|
| Debt / Equity |
0.62×
|
0.70×
|
| Dividend Yield |
1.1%
|
0.5%
|
| RSI (14) |
44.6
|
65.2
|
| Beta |
0.771
|
1.063
|
| Expected Upside |
+13.1%
|
+38.6%
|
AI Committee View
Current Innellis committee reasoning for SYK versus UHS.
UHS leads by 7 points.
UHS scores 66/100 (Buy) versus SYK at 59/100 (Buy).
SYK Committee View
60% agreement
5 analysts
Positive signals support the current rating — eps growing 27.7% yoy. The committee sees sufficient evidence to maintain the constructive view.
Bull Case
- ROE of 16.4% shows genuine earnings power backing the valuation — Value
- EPS growing 27.7% YoY — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
Bear Case
- P/E of 35.2 is moderate-to-rich — Value
- Price-to-book of 6.0x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
UHS Committee View
80% agreement
5 analysts
The primary driver is eps growing 29.4% yoy. Most analysts agree, and no major concerns are blocking a stronger rating.
Bull Case
- P/E of 6.8 is inexpensive for the broad market — Value
- ROE of 20.8% shows genuine earnings power backing the valuation — Value
- EPS growing 29.4% YoY — Growth
Bear Case
- MACD histogram is negative (-0.018) — bearish momentum.
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.